Sanford Guide Antimicrobial Therapy Editorial Board
Henry F. (Chip) Chambers, M.D.
Dr. Chambers is Professor of Medicine Emeritus at the University of California San Francisco (UCSF). He earned his undergraduate degree at Vanderbilt University and his medical degree at UCSF. His academic interests include antimicrobial resistance; genetics, molecular basis, and epidemiology of methicillin-resistance in Staphylococcus aureus; staphylococcal infections and tuberculosis. He joined the editorial board in 2007. Full bio.
Michael S. Saag, M.D.
Dr. Saag is Associate Dean for Global Medicine, Professor of Medicine, and Director of the Center for AIDS Research at the University of Alabama at Birmingham. Dr. Saag is an internationally recognized AIDS expert and served as HIV Medicine Association member of the IDSA Board of Directors. He joined the editorial board in 2007. Full bio.
Andrew T. (Andy) Pavia, M.D.
Dr. Pavia is Professor of Pediatrics and Medicine at University of Utah School of Medicine in Salt Lake City. Dr. Pavia's interests have focused on HIV/AIDS and the epidemiology of emerging infections and vaccine-preventable diseases. He serves as Co-Chair of the Pandemic Influenza Task Force of the IDSA. He has served as a contributing editor since 2003 and has expanded his role in 2013 to fully cover pediatrics content. Full bio.
Douglas Black, Pharm.D.
Dr. Black is Professor Emeritus of Pharmacy at the University of Washington in Seattle, WA. Doug's expertise is in the field of pharmacology of anti-infective agents. He joined the editorial board as a contributor in 2012, and is also the principal author of The Sanford Guide's monthly ID Update e-newsletter. Full bio.
Helen Boucher, M.D.
Dr. Boucher is the Dean and Professor of Medicine at Tufts University School of Medicine and Chief Academic Officer of the Tufts Medicine Health System. An active Infectious Diseases physician, she was previously Chief of the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center, and Director of the Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance (Levy CIMAR). Full bio.
David O. Freedman, M.D.
Dr. Freedman is Professor Emeritus of Infectious Diseases at University of Alabama at Birmingham. His academic interests for the past 35 years cover the fields of tropical and parasitic diseases, vaccinology, as well as biosurveillance of infectious diseases in returned travelers. David joined the editorial board as a contributor in 2012. Full bio.
Kami Kim, M.D.
Dr. Kim is Szentivanyi Professor of Internal Medicine and Director, Division of Infectious Diseases and International Medicine, at Morsani College of Medicine, University of South Florida, Tampa. She has led the clinical and research response to COVID at USF and Tampa General Hospital. Her basic laboratory work focuses on the pathogenesis of toxoplasmosis and malaria and the host response to infections. She is a graduate of Harvard University and Columbia College of Physicians and Surgeons. Full bio.